After handing off operations and biology management to new VPs, now focusing on accelerated development of new platforms for imaging tissue and liquid biopsy samples.

Managed the research and product development groups for systems, consumables and reagents while coordinating the facility move from South Lake Union to new corporate headquarters in Belltown.

One of a 4 person team leading the Cell Analysis Business segment within Genomics & Cellular ResearchTook on role to reverse the integration of the Cell Analysis business to allow more business centric decision making and improve customer serviceDesigned organization for worldwide sales, applications, service support directed by management from Issaquah locationProvided all IP oversight including tech evaluation, intake, prosecution, and out-licensing decisions

Led technology evaluation board to identify promising areas to pursue from internal, academic, and commercial sourcesManaged IP related investments for new and continuing prosecution of patent portfolio for Cell Analysis businessBegan cross site coordination with GE teams in India, Cardiff, Uppsalla, Issaquah, GRC (Niskyuna, NY)

Acted as R&D interface to GE during the integration of Applied Precision Inc. Took over management of HCA engineering within GE in Piscataway NJ. (Integration of Imaging Research Incorporated from years before)Supported transition of procedures to attain ISO 9001 certification of the Issaquah siteTransitioned HCA SW work from contractors in China and Canada to GE’s Healthcare team in India, Developed low cost wide field imaging system with apps based acquisition and analysis software for image cytometer market: CytellActed as R&D interface to GE during organizational change from Cell Technologies to Research and Applied MarketsBuilt a SW team in San Ramon to leverage GE Corporate investment in world class software COE. Initiated investment in ground-up data management and image analysis SW for HCA & microscopy marketsDeveloped compact version of SIM platform into one box with addition of new modalities for market leading 2D SIM imaging in TIRF: OMX SR

Developed a line-scan confocal HCA imaging system variant of the InCell 2000 as an OEM product for GEHC life Sciences: InCell 6000Tech transfer of technology of Structured Illumination Microscopy from UCSF, design and build of 7 early adopter systems: OMX V2Developed commercial version of SIM system with rebuilt software and industrial designed packaging: OMX V3Tech transfer of technology for market leading TIRF technique from Yale University, Developed option for OMX V3 platformDeveloped new optical engine to enable SIM at speeds required for live cell imaging in parallel with new platform to support lower cost configurations: OMX V4, Blaze optionSupported competitive process to sell the company resulting in GE acquisition May 2011

Developed a large format, 2D fluorescence gel imaging platform as an OEM product for GE Healthcare Discovery Systems group: Ettan DIGE Imaging systemDeveloped a 6 channel, 4 objective, wide-field HCA imaging system with live cell capabilities and liquid handling as an OEM product for GEHC Life Sciences: InCell 2000

Developed a line of OEM microarray scanners sold direct and later bundled with GE Codelink products: ArrayWoRx, ArrayWoRx/eDeveloped a compact, single lens HCA system sold direct and through Cellomics: ArrayScan, CellWoRx Developed 5 R&D prototypes of high performance microarray scanners for a large OEM to support their product development requirementsDeveloped a fully automated, 60X oil immersion, fluorescent imaging system for low copy detection for a local OEM Startup

Established OEM relationship with Applied Materials, a dominant player in Semiconductor manufacturing and developed a custom OEM product for EPI reactor gas controlIterated the product for reduce cost, increase performance, and adapt to different configurations of EPI reactors (200mm, 300mm, number of chambers per system etc.)

Circuit board design and system integration of dominant products in the semiconductor probe card analyzer market: Checkpoint, PrecisionPointCompleted debug and transfer to production of positioning system electronics for first FDA approved automated cancer detection system (OEM customer: Neopath, Tripath, now BD)Manufacturing support for OEM micropositioners and control electronics used in API systems and sold as OEM through Melles Griot: NanomotionCompleted redesign of control electronics to update OEM finger print scanning system: Morpho Systems Designed next generation positioning platform for internal and OEM applications: Nano2